Live
ScienceAncient wars between microbes gave us key immune defensesClinical OMICsNext-Generation Cardiac AI System Outperforms Existing ModelsClinical OMICsOpen-Source Algorithm Advances Precision Menstrual Health Beyond FertilityEndpoints NewsHow a group of biotechs ran a covert campaign to push out the FDA commissionerClinical OMICsOncology’s Next AI Battleground: Instant Clinical and Commercial InsightBioWorldAppointments and advancements for May 21, 2026BioWorldFinancings for May 21, 2026BioWorldIn the clinic for May 21, 2026BioWorldOther news to note for May 21, 2026BioWorldRegulatory actions for May 21, 2026BioPharma DiveRA Capital banks $75M for a biotech SPACEndpoints NewsChina’s drugmakers to take the stage at #ASCO26
Agilent Apr 6, 2026

Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $160, Maintains Outperform Rating - marketscreener.com

Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $160, Maintains Outperform Rating - marketscreener.com

Original
Body unavailable. Use the original source.